인쇄하기
취소

Dong-wha licensing in a new technology for anti-viral drugs

Published: 2005-05-10 06:54:00
Updated: 2005-05-10 06:54:00
Dong-wha announced to license in a new technology development for an anti-viral drug using natural plants from Korea Bio Engineering Research Institute, which was accomplished by the chief researcher Kwon Doo-han of the Cell Biology Research Div.

Dong-wha will pay a royalty amounted to the total 1 billion won of front payment and 5% of revolving royalty on the sales in return of its exclusi...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.